Home/Filings/4/0001127602-23-004055
4//SEC Filing

Goyal Jaya 4

Accession 0001127602-23-004055

CIK 0001835597other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:42 PM ET

Size

19.5 KB

Accession

0001127602-23-004055

Insider Transaction Report

Form 4
Period: 2023-02-06
Goyal Jaya
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-06$10.88/sh+1,677$18,2461,677 total
  • Sale

    Common Stock

    2023-02-06$17.04/sh1,677$28,5680 total
  • Exercise/Conversion

    Common Stock

    2023-02-08$10.88/sh+644$7,007644 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-02-061,677148,519 total
    Exercise: $10.88Exp: 2031-11-10Common Stock (1,677 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-02-073,679144,840 total
    Exercise: $10.88Exp: 2031-11-10Common Stock (3,679 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-02-08644144,196 total
    Exercise: $10.88Exp: 2031-11-10Common Stock (644 underlying)
  • Sale

    Common Stock

    2023-02-08$17.00/sh644$10,9480 total
  • Exercise/Conversion

    Common Stock

    2023-02-07$10.88/sh+3,679$40,0283,679 total
  • Sale

    Common Stock

    2023-02-07$17.18/sh3,679$63,2130 total
Footnotes (4)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2022.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]This stock option vests over four years following the vesting commencement date (October 15, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date.

Issuer

PepGen Inc.

CIK 0001835597

Entity typeother

Related Parties

1
  • filerCIK 0001922548

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:42 PM ET
Size
19.5 KB